OXT and Parkinson disease: Among the common for different treatments overrepresented (FDR < 0.1) KEEG pathways, there were, e.g., Parkinson disease, thermogenesis, RNA degradation, vascular smooth muscle contraction, platelet activation, oxytocin signaling pathway, and calcium signaling pathway (Supplementary File 8; Table 2).